Professor Dame Sue Hill is Chief Scientific Officer for England at NHS England and Head of Profession for the healthcare science workforce. A respiratory scientist by background, she has led major national programmes spanning diagnostics, workforce development and genomic medicine.

She is the Senior Responsible Officer for Genomics in NHS England and has been instrumental in establishing the NHS Genomic Medicine Service. She previously led the NHS contribution to the 100,000 Genomes Project, helping embed genomics into routine clinical care. Dame Sue has also driven large-scale education and training reform through the Modernising Scientific Careers initiative, standardising training across more than 50 scientific specialisms.

She played a central role in the UK’s COVID-19 testing and sequencing response. Dame Sue was awarded an OBE in 2005 and made a Dame Commander in 2018 for services to healthcare science and genomics.

Dr Catalina López Correa is a genomics leader with extensive experience across national and international genomics programmes. She has held senior leadership roles across Canada’s genomics ecosystem, including Chief Scientific Officer positions at Genome Québec, Genome British Columbia and Genome Canada.

She led the Canadian COVID-19 Genomics Network (CanCOGeN), embedding genomics within the national pandemic response and strengthening coordination across research, public health and clinical systems.

A physician and genomics advocate, Catalina is committed to advancing equitable access to genomic medicine globally, with a particular focus on underserved regions. She is also the Founder of Global Gene, an initiative focused on genomics education and engagement. She has received multiple honours, including the Canadian Senate 150th Anniversary Medal and the Colombian National Order of Merit.

Dr Bruce Korf is Distinguished Professor Emeritus of Genetics at the University of Alabama at Birmingham (UAB), where he previously served as Chair of Genetics, Associate Dean for Genomic Medicine and Chief Genomics Officer.

He is a past president of the American College of Medical Genetics and Genomics and the Association of Professors of Human and Medical Genetics. His work has contributed significantly to genomic medicine, particularly in neurofibromatosis and rare disease research.

Dr Korf has led major national initiatives including the Neurofibromatosis Clinical Trials Consortium and the Alabama Genomic Health Initiative, and is a principal investigator in the NIH All of Us Research Program. He is also a leading academic author and editor in human genetics, contributing to key textbooks and journals in the field.

Professor Gabriela Repetto is a Clinical Geneticist and Professor of Genetics at Clínica Alemana Universidad del Desarrollo in Santiago, Chile, where she founded the Center for Genetics and Genomics and currently directs the Rare Diseases Program.

She has held leadership roles including President of the Chilean Society of Genetics and membership of the Chilean Academy of Medicine. She also contributes to national and international advisory groups, including the World Health Organization’s Technical Advisory Group on Genetics.

Professor Repetto is committed to advancing genomics education and integrating genetics into undergraduate and clinical training. Her work focuses on strengthening capacity in rare diseases and ensuring that future healthcare professionals are equipped with genomic knowledge and skills.

Dr Vicky Nembaware is a Senior Lecturer at the University of Cape Town and a genomics leader focused on workforce development and capacity building across Africa and globally.

She has led major training and research initiatives, including roles as Project Manager for the Sickle Africa Data Coordinating Center and as training coordinator for H3Africa. Her work spans bioinformatics, public health genomics and programme design, with a strong emphasis on strengthening clinical and research capacity in diverse health systems.

Dr Nembaware serves as Secretary of the African Society of Human Genetics and is a strong advocate for equitable access to genomics education. She holds a PhD in Bioinformatics and is widely recognised for her leadership in training and collaborative genomics initiatives.

Dr Yosr Hamdi is a researcher at the Institut Pasteur of Tunis specialising in cancer genomics and precision medicine. She is a member of the World Health Organization’s Technical Advisory Group on Genomics and contributes to multiple international initiatives across Africa and globally.

Her work spans genomic research, policy and implementation, including leadership roles in the Genome Tunisia Collaborative Alliance and the PerMediNA Consortium, advancing personalised medicine in North Africa.

Dr Hamdi is a member of several high-profile advisory groups and Lancet Commissions focused on cancer genomics and precision health. She combines expertise in molecular biology, bioinformatics and clinical research to support the development of genomic medicine in underrepresented populations.

Professor Sir Mark Caulfield is Professor of Clinical Pharmacology at Queen Mary University of London and Vice Principal for Health. He is a leading figure in genomic medicine and translational research.

He was Chief Scientist for Genomics England and played a central role in delivering the 100,000 Genomes Project, helping to establish genomic medicine within the NHS. His work has contributed to gene discovery in cardiovascular disease, cancer and rare conditions, influencing clinical guidelines internationally.

Professor Caulfield has received numerous awards for his research and leadership, including a knighthood in 2019. He continues to contribute to national and international health systems through leadership roles across academic and clinical organisations.

Professor Vajira Dissanayake is Dean of the Faculty of Medicine at the University of Colombo, Sri Lanka, and a leader in genomics, digital health and medical education.

He has held numerous national and international leadership roles, including positions within the Commonwealth and advisory roles to the World Health Organization. His work focuses on integrating genomics and digital health into healthcare systems and education.

Professor Dissanayake has been instrumental in advancing health informatics and genomic medicine in Sri Lanka and beyond. He is a Fellow of multiple international academies and was awarded the Sri Lankan national honour Vidya Jyothi for his contributions to science and medicine.

Dr Wadha Al Muftah is a physician-scientist and healthcare executive with over 17 years’ experience leading national-scale precision medicine and genomics initiatives.

She is a founding leader of the Qatar Genome Programme and currently serves as Chief Medical Officer at the Qatar Precision Health Institute. Her work focuses on integrating genomics into clinical care and delivering population-level impact aligned with national health priorities.

Dr Al Muftah has extensive experience in building and scaling complex, multi-stakeholder programmes and brings deep knowledge of healthcare systems, policy and implementation. She is recognised for her leadership in advancing precision medicine in the Middle East and internationally.

Associate Professor Azure Hermes is Deputy Director of the National Centre for Indigenous Genomics at the Australian National University. A proud Gimuy Walubara Yidinji woman, she brings a strong focus on Indigenous leadership and community engagement in genomics.

Her work centres on ensuring that genomic research involving Indigenous populations is conducted ethically, with respect for cultural values and data sovereignty. She leads national partnerships and engagement with Aboriginal and Torres Strait Islander communities.

Azure is committed to making genomics accessible and relevant to communities and to ensuring that research delivers tangible benefits. Her leadership contributes to shaping more inclusive and equitable approaches to genomics in Australia and globally.

Jillian Hastings Ward MBE is a patient advocate with lived experience of rare disease and a leading voice for patient involvement in genomics.

She was a founding member and former Chair of the Participant Panel at Genomics England and has held multiple advisory roles across UK genomics and rare disease initiatives. She was awarded an MBE for services to patients and participants in genomics.

Jillian has contributed to the development of global training programmes in patient advocacy and continues to champion meaningful patient engagement in research and healthcare. Her work ensures that patient perspectives are embedded in the development and implementation of genomic medicine.

Kate Orviss is Chief Executive Officer of the Global Genomics Network for Education and Training (GGNET), where she provides strategic leadership as the Network develops as an independent global platform for collaboration, knowledge-sharing and capacity building in genomics education and training.

She brings extensive experience across global genomics, policy, governance and international convening. She has designed and led international initiatives and built partnerships across governments, academia, industry, philanthropy and multilateral organisations, with a focus on advancing collaboration and strengthening health systems.

Kate began her career as a solicitor and spent nearly two decades at Pinsent Masons LLP, where she was appointed Partner in 2010. She advised governments and public institutions on complex healthcare and infrastructure projects across multiple jurisdictions. Her work focuses on strengthening global capacity in genomics education and training and supporting the development of sustainable, equitable genomic medicine systems internationally.

Claire Healy is Global Network Manager for the Global Genomics Network for Education and Training (GGNET), where she is responsible for operational coordination across the network and supporting the delivery of its strategic objectives.

She leads the development and management of GGNET’s digital platform and provides coordination and secretariat support to the Board of Trustees. She works closely with the CEO and, as regional structures are established, will support regional secretariats to ensure consistent standards and effective collaboration across the global network.

Alongside her role in GGNET, Claire is a Project Coordinator within NHS England’s Genomics Education Programme, where she supports national initiatives and the delivery of the Master’s in Genomic Medicine framework. She brings over 18 years’ experience from the private sector and is committed to enabling collaboration and strengthening global engagement in genomics education and training.